Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-market, Multicenter, Prospective, Clinical Study to Evaluate the Nevro1 Sacroiliac (SI) Transfixing and Fusion System for the Treatment of Sacroiliac Joint Dysfunction

NCT06909292 is registered in ClinicalTrials.gov with Nevro Corp as lead sponsor.

NCT NCT06909292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06909292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-market, Multicenter, Prospective, Clinical Study to Evaluate the Nevro1 Sacroiliac (SI) Transfixing and Fusion System for the Treatment of Sacroiliac Joint Dysfunction
Lead sponsor
Nevro Corp
Phase
Observational
Overall status
Completed
Start date
April 3, 2025
Completion date
May 21, 2025
Enrollment
180 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

sacroiliac joint dysfunction